Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd (BSE Scrip Code: 531380) submitted copies of newspaper advertisements containing its standalone unaudited financial results for the quarter and nine months ended December 31, 2025, published on February 14, 2026 in New Hub and the Mumbai edition of Pratahkal, as required under Regulation 47 of SEBI LODR. For Q3 FY26, revenue from operations rose to Rs. 1,491.54 lakhs from Rs. 1,220.39 lakhs in Q3 FY25 (about 22% YoY growth), and the company swung to a profit after tax of Rs. 14.70 lakhs compared with a loss of Rs. 84.77 lakhs in the same quarter last year. For the nine-month period, revenue grew modestly to Rs. 4,135.75 lakhs (vs Rs. 4,027.87 lakhs), while profit after tax stood at Rs. 10.88 lakhs versus a loss of Rs. 28.02 lakhs a year earlier. EPS for the quarter was Rs. 0.40 against a loss of Rs. 2.30, and for nine months it was Rs. 0.30 against a loss of Rs. 0.76.
The filing is a routine compliance disclosure of already-filed quarterly numbers and is unlikely to move the stock on its own. However, the underlying results show a clear turnaround — moving from losses to profits on both a quarterly and year-to-date basis along with healthy revenue growth — which is a positive signal for shareholders about the company's improving operating performance.